BNP PARIBAS FINANCIAL MARKETS - VANDA PHARMACEUTICALS INC ownership

VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 166 filers reported holding VANDA PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 2.80 and the average weighting 0.1%.

Quarter-by-quarter ownership
BNP PARIBAS FINANCIAL MARKETS ownership history of VANDA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$170,165
-66.9%
39,390
-49.4%
0.00%
-100.0%
Q2 2023$513,506
-53.3%
77,922
-51.9%
0.00%
-50.0%
Q1 2023$1,099,994
+108.4%
162,002
+126.8%
0.00%
+100.0%
Q4 2022$527,860
-99.9%
71,429
-14.9%
0.00%0.0%
Q3 2022$829,505,000
+272.2%
83,958
+310.6%
0.00%
Q2 2022$222,861,000
-18.9%
20,446
-15.9%
0.00%
Q1 2022$274,923,000
-51.3%
24,308
-32.5%
0.00%
-100.0%
Q4 2021$564,981,000
-49.8%
36,009
-45.2%
0.00%
-50.0%
Q3 2021$1,126,321,000
+80.3%
65,713
+126.2%
0.00%
+100.0%
Q2 2021$624,866,000
+38.2%
29,050
-3.5%
0.00%0.0%
Q1 2021$452,207,000
+17.8%
30,107
+3.0%
0.00%0.0%
Q4 2020$383,964,000
+189.5%
29,221
+112.8%
0.00%
Q3 2020$132,641,000
-80.3%
13,731
-76.7%
0.00%
-100.0%
Q2 2020$674,079,000
+114.8%
58,923
+94.5%
0.00%0.0%
Q1 2020$313,887,000
+61.7%
30,298
+156.2%
0.00%
Q4 2019$194,081,000
+78.4%
11,827
+44.4%
0.00%
Q3 2019$108,790,000
+34.7%
8,192
+42.9%
0.00%
Q2 2019$80,792,000
-58.9%
5,734
-46.3%
0.00%
Q1 2019$196,622,000
+44184.2%
10,686
+62758.8%
0.00%
Q4 2018$444,000
-98.9%
17
-99.0%
0.00%
Q3 2018$39,084,000
+20.5%
1,7030.0%0.00%
Q2 2018$32,442,000
-79.4%
1,703
-81.8%
0.00%
Q1 2018$157,413,000
+11.7%
9,342
+0.8%
0.00%
Q4 2017$140,889,000
+74.8%
9,269
+105.8%
0.00%
Q3 2017$80,622,000
+3.3%
4,504
-5.9%
0.00%
Q2 2017$78,044,000
+2593.0%
4,788
+2213.0%
0.00%
Q1 2017$2,898,000
-91.1%
207
-89.9%
0.00%
Q4 2016$32,745,000
-22.4%
2,053
-19.0%
0.00%
Q3 2016$42,199,000
-91.3%
2,536
-94.2%
0.00%
-100.0%
Q2 2016$486,888,000
+38.3%
43,511
+3.4%
0.00%
+100.0%
Q1 2016$351,956,000
-59.7%
42,100
-55.1%
0.00%
-50.0%
Q4 2015$872,458,000
+754.4%
93,712
+935.1%
0.00%
Q3 2015$102,118,000
+131.4%
9,053
+160.4%
0.00%
Q2 2015$44,123,000
+410.7%
3,477
+274.3%
0.00%
Q1 2015$8,640,000
-59.0%
929
-54.3%
0.00%
Q3 2014$21,092,000
+295.3%
2,032
+372.6%
0.00%
Q4 2013$5,336,000
-94.5%
430
-96.4%
0.00%
Q2 2013$97,590,00012,0780.00%
Other shareholders
VANDA PHARMACEUTICALS INC shareholders Q3 2020
NameSharesValueWeighting ↓
Palo Alto Investors LP 2,491,200$27,154,0002.37%
Profit Investment Management, LLC 281,890$3,071,0002.26%
Sio Capital Management, LLC 488,965$5,330,0002.00%
Zebra Capital Management LLC 14,766$161,0000.47%
Prairiewood Capital, LLC 50,165$547,0000.43%
TANG CAPITAL MANAGEMENT LLC 256,696$2,798,0000.42%
HUSSMAN STRATEGIC ADVISORS, INC. 156,000$1,700,0000.29%
GLOBEFLEX CAPITAL L P 100,843$1,099,0000.27%
Epoch Investment Partners, Inc. 2,757,646$30,059,0000.18%
EMC Capital Management 16,185$176,0000.15%
View complete list of VANDA PHARMACEUTICALS INC shareholders